EUCTR2015-003012-21-ES进行中（未招募）不适用
Identification of tissue biomarkers related to late toxicity in Head and Neck Cancer Patients treated with chemoradiotherapy or bioradiotherapy - BioLateTox
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Signed Informed Consent
- •2. Age >18 years
- •3. Histologically confirmed diagnosis of LAHNC.
- •4. Candidate to radical treatment with chemoradiotherapy or biochemotherapy
- •5. Ability to understand the purpose and procedures associated to the study, to understand the language in which the information sheet is given, and to give informed consent after instructed about possible complications derived from the study procedures.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 60
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •1. Patients with LAHNC who are candidates for surgery as radical treatment.
- •2. Any medical condition that makes the patient unfit to receive radiotherapy, chemotherapy or treatment with cetuximab according to the corresponding group.
- •3. Any inflammatory skin condition
- •4. Any known pathology that might interfere with the test results (e.g rheumatoid arthritis, Systemic Lupus Erythematosis, arachnodactyly, dermatomyositis, etc)
- •5. Any medical condition that increases the risk of complication related to a skin biopsy (e.g. severe skin diseases, anticoagulant therapy)
- •6. Any social or geographic situation which might interfere with the patient?s ability to attend follow-up visits.
研究者
相似试验
尚未招募
不适用
Identification of biomarkers and pathogenesis of lung cancer without targeted metabolomics based on uplc-q-tof /MSung cancerITMCTR1900002555The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
招募中
不适用
Identification and analysis of biomarkers for the course of demyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosisDemyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosisDRKS00031139MPI-NAT1,000
招募中
不适用
Identification of biomarkers for diagnosis and prognosis in the patients with obstructive sleep apneaobstructive sleep apneaJPRN-UMIN000021503Osaka university graduate School of medicine The department of geriatric and general medicine200
招募中
不适用
Investigation of clinical biomarkers reflecting the neurological basis of depressive symptoms and their usefulness in novel therapeutic techniquedepressive symptomsJPRN-UMIN000026411Gunma University210
招募中
不适用
Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)Coronavirus Disease 19 (COVID-19)U07.1J12J13J14J15J16J17J18COVID-19, virus identifiedViral pneumonia, not elsewhere classifiedPneumonia due to Streptococcus pneumoniaePneumonia due to Haemophilus influenzaeBacterial pneumonia, not elsewhere classifiedPneumonia due to other infectious organisms, not elsewhere classifiedPneumonia in diseases classified elsewherePneumonia, organism unspecifiedDRKS00022871CAPNETZ STIFTUNG, Geschäftsstelle an der Medizinischen Hochschule Hannover400